Agios Pharmaceuticals, Inc.AGIONASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+14.0%
5Y CAGR+11.2%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+14.0%/yr
vs +1.6%/yr prior
5Y CAGR
+11.2%/yr
Consistent
Acceleration
+12.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $180.28M | +15.0% |
| 2024 | $156.78M | +30.8% |
| 2023 | $119.90M | -1.5% |
| 2022 | $121.67M | +0.2% |
| 2021 | $121.44M | +14.4% |
| 2020 | $106.12M | -19.6% |
| 2019 | $132.03M | +15.7% |
| 2018 | $114.14M | +60.5% |
| 2017 | $71.12M | +40.2% |
| 2016 | $50.71M | - |